CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study. [electronic resource]
- Rheumatology (Oxford, England) Jan 2008
- 45-9 p. digital
Publication Type: Journal Article
1462-0332
10.1093/rheumatology/kem313 doi
Chemokine CCL2--blood Chemokine CXCL10--blood Disease Progression Female Humans Longitudinal Studies Male Middle Aged Scleroderma, Systemic--blood Time Factors